INTRODUCTION
============

Glycoconjugates that cover cell surfaces play a significant role in a large number of biological processes, including cell adhesion, signal transduction, and receptor activation ([@b5-molcell-38-1-65]; [@b28-molcell-38-1-65]; [@b32-molcell-38-1-65]). Thus, a number of studies on protein glycosylation have revealed their structure and function for the governance of *in vivo* physiologies and diseases ([@b1-molcell-38-1-65]; [@b8-molcell-38-1-65]; [@b23-molcell-38-1-65]; [@b33-molcell-38-1-65]; [@b37-molcell-38-1-65]). In xenotransplantation, the galactose-alpha-1,3-galactose (α-Gal) carbohydrate antigen expressed in pig tissues had been regarded as the most important xenoantigen that interacts with natural α-Gal antibodies responsible for hyper acute rejection (HAR) in pig-to-human xenotransplantation ([@b34-molcell-38-1-65]). To overcome this barrier to successful xenografts, several groups successfully produced GalT-KO pigs that do not express the α-Gal antigens ([@b6-molcell-38-1-65]; [@b20-molcell-38-1-65]; [@b21-molcell-38-1-65]). Nonetheless, the non-Gal antigens originally present on pig cell surfaces induce complement mediated lysis and antibody dependent cellular cytotoxicity (ADCC) of pig cells by binding to non-Gal anti-pig natural antibodies in human serum ([@b3-molcell-38-1-65]). In addition, it has been reported that the knockout of pig α1,3-galactosyltransferase gene results in alteration of the expression of carbohydrate antigens expressed on the pig cell surface ([@b7-molcell-38-1-65]; [@b24-molcell-38-1-65]; [@b29-molcell-38-1-65]; [@b31-molcell-38-1-65]). More recently, [@b22-molcell-38-1-65] produced double knockout pigs deficient in α-Gal and NeuGc epitopes and [@b4-molcell-38-1-65] reported on *N*-glycosylation changes in pig serum caused by knockout of the α-Gal/NeuGc-related genes. Thus, qualitative and quantitative analysis of pig cell glycans containing non-Gal antigens is preferentially required prior to therapeutic strategies (e.g., genetic modifications) aimed at preventing xenograft rejection in xenotransplantation.

Mass spectrometric techniques have been a powerful tool for the analysis of cellular glycans, which possess great complexity and diversity in structure ([@b12-molcell-38-1-65]; [@b27-molcell-38-1-65]). In contrast to the indirect method of lectin or glycan-binding antibody-based assays, MS analysis directly enables complete characterization of glycan structures. Moreover, several attempts for MS-based quantitation have been recently reported, and these have been found to have good quantitative performance when compared to high-performance liquid chromatography (HPLC) ([@b10-molcell-38-1-65]; [@b11-molcell-38-1-65]; [@b13-molcell-38-1-65]; [@b15-molcell-38-1-65]; [@b35-molcell-38-1-65]). Recent studies on GalT-KO pigs reported glycolipid analysis of pig tissues and cells using an LC-MS instrument, demonstrating that such a tool allowed researchers to characterize the glycolipid-derived glycan structures ([@b7-molcell-38-1-65]; [@b31-molcell-38-1-65]). However, the LC-MS and lectin immunostaining methods used in previous studies are limited because they cannot provide reliable quantitative information regarding the individual glycans present on pig cells and tissues.

In this study, we report on the identification of *N*-glycans derived from WT and GalT-KO pig fibroblasts. We also provide a quantitative comparison of the *N*-glycosylation profiles between these pig cells using MS-based approaches. MS combined with solid-phase permethylation enable both quantitative and qualitative analysis of cellular glycans. We identified diverse *N-*glycans, including high-mannose type and complex type glycans on pig fibroblasts. In particular, we found that the relative quantity of sialic acid-containing glycans increased in GalT-KO, and the amount of NeuGc, considered to be a promising non-Gal antigen, was slightly higher in GalT-KO than in WT. This qualitative and quantitative information is expected to be valuable for successful xenotransplantation.

MATERIALS AND METHODS
=====================

Chemicals and reagents
----------------------

Sodium hydroxide (beads, 20--40 mesh), 5-dihydroxybenzoic acid (DHB), dimethyl sulfoxide (DMSO), methyl iodide, and trifluoroacetic acid (TFA) were purchased from Sigma-Aldrich (USA). Peptide *N*-glycosidase F (PNGase F) was obtained from Roche (Germany). Porous graphitic carbon (PGC) cartridge was purchased from Thermo Scientific (USA) and Microspin column was obtained from Harvard Apparatus (USA). Acetic acid, acetonitrile (ACN), and chloroform were purchased from Junsei (Japan). All aqueous solutions were prepared with ReadyPrep™ Proteomic Grade Water (Bio-Rad, USA).

Isolation of homozygous GalT-KO cells
-------------------------------------

The Institutional Animal Care and Use Committee of the Dankook University approved all animal procedures. Fibroblasts were cultured from ear skin biopsies of the heterozygous GalT-KO piglets as previously reported ([@b2-molcell-38-1-65]). Selection of homozygous GalT-KO cells derived from the loss of heterozygosity was performed as described elsewhere ([@b9-molcell-38-1-65]). Briefly, 5 × 10^5^ heterozygous GalT-KO cells were washed twice with Dulbecco's phosphate buffered saline (DPBS), resuspended with 1 ml of DPBS containing 4 μg biotinconjugated IB4-lectin (EY Laboratories, USA), a lectin that specifically binds to Galα1,3Gal epitopes, in a 1.5-ml tube, and incubated for 1 h on ice while tapping the tube to prevent precipitation of the cells. After washing cells twice with DPBS by centrifugation, 4 mg of Dynabeads M-280 Streptavidin (Invitrogen, USA) was added to the pellet, and the resulting mixture was again incubated with the IB4-lectin treatment. Then, the tube was placed on a magnet for 2--3 min, and the supernatant was transferred to a new tube on a magnet. This procedure was repeated three times. The final supernatant was cultured in Dulbecco's modified Eagle medium (DMEM) containing 10% (v/v) fetal bovine serum (FBS) in 60-mm culture dish for 10--14 days until colonies reached approximately 2 mm in diameter. The culture dish containing fibroblast colonies was washed twice with DPBS and covered with dimethylpolysiloxane (DMPS). Colonies were dissociated by injecting 30 μl of 0.25% trypsin-EDTA on top of each colony underneath DMPS using a micropipette. After incubation for 5 min at 39°C, fibroblasts dissociated from each colony were transferred onto 0.1% gelatin-coated 24-well culture dish for clonal culture. Clones of homozygous GalT-KO were analyzed by PCR as previously reported ([@b2-molcell-38-1-65]). Briefly, genomic DNA was prepared from fibroblasts using DNeasy Tissue Kit (Qiagen, USA) according to the manufacturer's protocol. Using Maxime PCR premix kit (Intron Biotechnology, Korea) in a 20 μl reaction volume, amplification of the target gene was carried out using forward 5′-AGAGGTCGTGACCATAACCAGAT-3′ and reverse 5′-AGCCCATGCTGAACATCAAGTC-3′ primers. Conditions for PCR were as follows: 30 cycles of 15 s at 94°C, 30 s at 65°C, 10 min + 20 s increase/cycle at 68°C; and one final 7 min cycle at 68°C. Amplification products (9.2 kb GalT gene-targeted and/or 7.4 kb wild type allele) were analyzed by 0.4% agarose gel electrophoresis. Fibroblasts confirmed to be GalT-KO were used for subsequent experiments.

Membrane fractionation from pig fibroblasts
-------------------------------------------

Cell membrane fractionation was performed following descriptions in a previous study ([@b18-molcell-38-1-65]), with minor modifications. Briefly, pig fibroblasts (WT and GalT-KO, respectively) consisting of 1 × 10^6^ ∼ 1 × 10^7^ cells were washed twice with 1 × phosphate buffered saline (PBS) by centrifugation at 90 × *g* for 5 min. The washed cell pellets were homogenized by sonication followed by centrifugation at 3,500 rpm (Hanil Research & Development Mircro17TR, Korea) for 10 min to remove cell debris and the nuclear fraction. The supernatant was centrifuged at 100,000 × *g* for 1 h and then precipitates (membrane fraction) were washed with 1 × PBS three times to remove the cytosol fraction. The washed precipitates were dissolved in 50 mM sodium phosphate buffer (pH 7.5) for further enzyme reaction.

Deglycosylation of membrane fractions
-------------------------------------

The membrane proteins were incubated at 95°C for 3 min for denaturation. The denatured proteins were added to 5 U of PNGase F and incubated at 37°C for 16 h for deglycosylation. The sample was added to a 4-fold volume of ethanol and incubated at −20°C for 2 h. The *N*-deglycosylated proteins were removed by centrifugation at 13,500 rpm for 15 min and supernatants containing *N*-glycans were carefully transferred to new tubes and dried in a vacuum evaporator for further purification.

Purification of *N*-glycans
---------------------------

The released *N*-glycans were purified using PGC. The PGC cartridge was washed with 6 mL of water and 3 ml of 50% (v/v) ACN/water containing 0.1% TFA. 1 ml of the sample in water was loaded on the cartridge and then washed with water and 5% (v/v) ACN/water containing 0.1% TFA to remove salts and other contaminants. The *N*-glycans were eluted with 50% (v/v) ACN/water containing 0.1% TFA and then completely dried for further glycan derivatization.

Permethylation of *N*-glycans
-----------------------------

The derivatization of the purified *N*-glycans was performed using a solid-phase permethylation method ([@b15-molcell-38-1-65]). Briefly, the *N*-glycans were resuspended in 141.6 μl of DMSO, 52.8 μl of iodomethane, and 5.6 μl of water. A NaOH-packed spin column was washed with ACN and DMSO and then the sample solution was loaded on the spin column followed by centrifugation at 1,200 rpm for 15 min. The step was repeated at least eight times for complete permethylation. The sample was collected and then extracted with 200 μl of chloroform and 200 μl of water by vortexing. The permethylated *N*-glycans in the organic solvent phase were dried prior to MS analyses.

MALDI-TOF MS/MALDI-QIT-TOF MS analysis
--------------------------------------

MS analysis was carried out using a matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) MS instrument with an Autoflex system from Bruker Daltonics (Bruker, Germany). Tandem mass spectrometric analysis was performed using an Axima Resonance MALDI-quadrupole ion trap (QIT)-TOF instrument (Shimadzu, UK). These mass spectrometers were operated in positive-ion reflectron mode. The matrix solution used was 10 mg/ml DHB in 50% methanol. Data acquisition and processing in MS and MS/MS analysis were performed with flexAnalysis 3.3 software (Bruker, Germany) and Launchpad 2.9.3 software (Kratos Analytical Ltd., UK), respectively. The mass spectrometric analysis was triplicated for all samples.

RESULTS
=======

Fibroblasts with biallelic disruption of the GalT gene resulting from loss of heterozygosity (LOH) in heterozygous GalT-KO were obtained by selection using IB4-Dynabead. As shown in [Fig. 1](#f1-molcell-38-1-65){ref-type="fig"}, PCR analysis confirmed that fibroblasts from the colony selected contained only the GalT gene-targeted allele (9.2 kb) without the wild type allele (7.4 kb), demonstrating that homozygous GalT-KO fibroblasts were successfully isolated.

In this study, we sought to identify *N*-glycans on the cell surface of WT and GalT-KO pig fibroblasts using an MS-based approach. The scheme for the proposed approach of this study is described in [Fig. 2](#f2-molcell-38-1-65){ref-type="fig"}. Cell membrane proteins were fractionated from pig fibroblast lysate *via* ultracentrifugation, and then *N-*glycans were released from the cell membrane proteins by peptide *N*-glycosidase F (PNGase F) digestion. Next, the released *N*-glycans were desalted using porous graphitic carbon (PGC) cartridges for the solid-phase extraction. Finally, the purified *N*-glycans were permethylated and subsequently analyzed *via* MALDI-TOF MS and MS/MS.

The representative MALDI spectra obtained from WT and GalT-KO pig fibroblasts are shown in [Fig. 3](#f3-molcell-38-1-65){ref-type="fig"}. The *N*-glycan profile showed a total of 47 *N*-glycans on pig fibroblasts, including high-mannose type glycans and complex type glycans with bi-, tri-, and tetra-antennary structures ([Table 1](#t1-molcell-38-1-65){ref-type="table"}). The predicted structures were proposed according to structural information obtained in our previous studies ([@b16-molcell-38-1-65]; [@b17-molcell-38-1-65]). The MS results also indicated that sialylated glycans and fucosylated glycans were abundant components of the complex-type glycans. Notably, the α-Gal antigen at an *m/z* value of 2652.4, considered to be the major xenoantigen, was not detected in Gal-KO pig fibroblasts but was observed in trace amounts in WT pig fibroblasts. This α-Gal xenoantigen, which was deduced to be a two α-galactosylated bi-antennary glycan due to its molecular weight, was previously found in other pig organs ([@b16-molcell-38-1-65]; [@b17-molcell-38-1-65]; [@b18-molcell-38-1-65]; [@b19-molcell-38-1-65]). We also confirmed that α-Gal-terminated *N*-glycan was absent in GalT-KO pig fibroblasts based on the MS profiles. On the other hand, five *N*-glycans (proposed to be NeuGc-containing glycans observed at *m/z* values of 2186.2, 2822.5, 2996.6, 3445.8, and 3806.7) were detected in both WT and GalT-KO pig fibroblasts.

To quantify the *N*-glycans in pig fibroblasts, we performed a MALDI-TOF MS-based quantitative analysis using solid-phase permethylation ([@b15-molcell-38-1-65]). The results showed that the relative quantities of sialylated (92.3%) glycans in GalT-KO pig fibroblasts were higher than those in WT (69.9%) ([Fig. 4a](#f4-molcell-38-1-65){ref-type="fig"}). Most notably, a sialylated glycan composed of Hex~5~HexNAc~4~Fuc~1~NeuAc~2~ was dramatically elevated in the GalT-KO (14.2%) fibroblasts relative to the WT fibroblasts (1.5%). In addition, Hex~5~HexNAc~4~Fuc~1~NeuAc~1~ and Hex~6~HexNAc~5~Fuc~1~NeuAc~2--3~ (2.5% and 2.9%, respectively) glycans were only observed or were increased in GalT-KO fibroblasts. Interestingly, we found that these increased sialylated glycans contained a core-fucose, and these glycans consequently played lead roles in the increase of overall fucosylation levels as well as in the sialylation of the pig GalT-KO, as shown in [Fig 4B](#f4-molcell-38-1-65){ref-type="fig"}. We also quantified NeuGc-containing *N-*glycans, and the result showed that the quantity of NeuGc antigens was slightly higher in GalT-KO (6.1%) compared to WT (4.5%) ([Fig. 4C](#f4-molcell-38-1-65){ref-type="fig"}).

We carried out tandem mass spectrometry analysis using MALDI-QIT TOF MS to validate the *N*-glycan structures in the pig fibroblasts. The above-mentioned Hex~5~HexNAc~4~Fuc~1~NeuAc~1--2~ and Hex~6~HexNAc~5~Fuc~1~NeuAc~2--3~ glycans were analyzed, and the relative quantities were higher in GalT-KO pig fibroblasts than in WT fibroblasts. As shown in [Fig. 5](#f5-molcell-38-1-65){ref-type="fig"}, the chemical structures of the glycans were elucidated by peak assignment of fragment ions in mass spectra and were therefore confirmed to be *N*-glycans containing both sialic acid and core-fucose residues. For example, fragment ions at *m/z* values of 2230.2, 2591.4, 3040.3, and 3401.4 were generated from parent ions at *m/z* 2605.4, 2966.6, 3415.7, and 3776.6, respectively, by the loss of an *N*-acetylneuraminic acid residue (375.2 Da). The parent ions also produced a fragment ion at *m/z* 1303.7 or 1317.7, corresponding to a fucosylated *N*-glycan core structure. In addition, the NeuGc-containing *N*-glycans Hex~5~HexNAc~4~ NeuAc~1~NeuGc~1~ and Hex~5~HexNAc~4~Fuc~1~NeuAc~1~NeuGc~1~ were confirmed by MS/MS analysis ([Fig. 6](#f6-molcell-38-1-65){ref-type="fig"}). For instance, fragment ions at *m/z* 2417.4 and 2591.3 were generated from parent ions at *m/z* 2822.5 and 2996.6 by cleavage of a NeuGc residue (405.1 Da).

DISCUSSION
==========

In the present study, the nature of *N*-glycans isolated from WT and GalT-KO pig fibroblasts was investigated. With respect to the carbohydrate antigen expressed on the surface of WT pig cells, an α-Gal antigen and two α-galactosylated bi-antennary glycans, were previously found in other pig organs ([@b16-molcell-38-1-65]; [@b17-molcell-38-1-65]; [@b18-molcell-38-1-65]; [@b19-molcell-38-1-65]). Quantitative MS and HPLC studies of pig glycans showed that this antigen was the most abundant α-Gal antigen in WT pig ([@b17-molcell-38-1-65]). We therefore suggested that the α-Gal-terminated biantennary glycan with a core fucose (Hex~7~ HexNAc~4~Fuc~1~) might be the only α-Gal antigen structure of *N*-glycans expressed in WT pig fibroblasts. However, the level of this α-Gal terminated *N*-glycan was fairly low in the pig fibroblasts used in this study. Recently, [@b24-molcell-38-1-65] indicated that the level of the α-Gal epitope in pig fibroblast glycolipid is also significantly lower than other glycoepitopes. Thus, this observation may suggest that WT pig fibroblasts express low levels of α-Gal antigen compared to other cells/tissues of pigs. However, although α-galactosylation does not seem to play a predominant role in fibroblast glycosylation, the disruption of α-galactosyltransferase may profoundly influence the expression of other carbohydrate epitopes. This study also indicates that NeuGc is still present on the cell surface of pig fibroblasts after deletion of the α1,3-galactosyltransferase gene, and thus, the NeuGc antigen may be the next hurdle for further studies in pig-to-human xenotransplantation, as described previously ([@b26-molcell-38-1-65]).

For quantitative comparison of *N*-glycans between WT and GalT-KO pig fibroblasts, MALDI-TOF MS analysis combined with solid-phase permethylation was performed. This approach has been reported to be a good quantitative method with excellent correlation to HPLC for reductive amination derivatization ([@b36-molcell-38-1-65]). Moreover, solid-phase permethylation minimizes sialic acid loss *via* oxidative degradation and peeling. It is therefore more accurate and efficient relative to conventional solution-phase permethylation ([@b14-molcell-38-1-65]). The quantitative result in the present study supports findings by recent studies on different organs of the GalT-KO pig ([@b29-molcell-38-1-65]; [@b30-molcell-38-1-65]). Park et al. used an enzyme-linked lectinosorbent assay method to report that α1,3-galactosyltransferase deficiency in pigs increased sialic acid-terminated glycoconjugate epitopes ([@b29-molcell-38-1-65]; [@b30-molcell-38-1-65]). This lectin-based method was able to analyze specific carbohydrate epitopes expressed on the cell surface but did not provide quantitative information on individual glycans or the glycan structures in the GalT-KO pig.

This study also reveals the increase of core-fucosylation levels in the pig GalT-KO through quantitative and structural MS analysis. However, a previous report indicated that there is no significant difference in fucose levels between GalT-KO and WT pig fibroblasts according to the lectin microarray-based glycomics ([@b24-molcell-38-1-65]). In contrast, Diswall et al. reported elevated fucose levels in glycolipids from GalT-KO pig tissues and structurally identified them with LC-MS and proton NMR ([@b7-molcell-38-1-65]). Thus, the potential role of the glycosyltransferases in GalT-KO pig remains to be elucidated.

The detection and quantitative measurement of NeuGc could not be carried out in previous studies because there was no available commercial lectin that specifically binds to the NeuGc epitope ([@b24-molcell-38-1-65]; [@b25-molcell-38-1-65]). Recently, Park et al. reported that quantification of NeuGc was performed *via* 1,2-diamino-4,5-methylenedioxybenzene (DMB) derivatization of sialic acids. However, they did not distinguish between the major glycan types, such as *N*- and *O*-glycans and glycolipid-derived glycans ([@b30-molcell-38-1-65]). Here, we performed *N-*glycan-specific analysis using PNGase F enzyme digestion, and thus we were able to use MS analysis to obtain more detailed information on the NeuGc-terminated *N*-glycan structure. Although the relative change in NeuGc quantity between WT and GalT-KO might not seem dramatic, the increase of the NeuGc antigen in the fibroblasts matched previous results on GalT-KO pig organs ([@b29-molcell-38-1-65]; [@b30-molcell-38-1-65]) indicating that the heart, liver, and kidneys of GalT-KO pigs had higher levels of NeuGc than did those of WT pigs. Two NeuGc-linked *N*-glycan structures from fibroblasts were investigated in this study. Unfortunately, it was difficult to assign the other *N*-glycans, which were expected to contain NeuGc residues, because their peak intensities were too low to be isolated in MS/MS. Nevertheless, we showed here that the MS-based approach enabled qualitative and quantitative analysis of cellular *N*-glycans, including xenoantigens from WT and GalT-KO pig cells. Taken together, we concluded that sialic acid-containing glycoconjugates with NeuGc antigen expression in pigs increased following deletion of the α1,3-galactosyltransferase gene.

In summary, a total of 47 *N*-glycans isolated from WT and GalT-KO pig fibroblasts were identified using an MS approach. We illustrated the relative change in *N*-glycosylation including NeuGc between WT and GalT-KO, suggesting that deletion of the α1,3-galactosyltransferase gene may not only remove the construction of the Galα1,3Gal residue, but may also increase the amount of sialylated glycans, including the NeuGc antigen. Therefore, this study provides important information for further research of pre-clinical trials involving GalT-KO pigs.
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![PCR analysis of genomic DNA from homozygous GalT-KO cells. Lane 1, 1 kb ladder; lane 2, wild-type cells; lane 3, heterozygous GalT-KO cells; lane 4, homozygous GalT-KO cells.](molcell-38-1-65f1){#f1-molcell-38-1-65}

![Overall strategy for N-glycan analysis of the pig fibroblasts using mass spectrometric technologies. The purified N-glycans from membrane fractions of the pig fibroblasts were permethylated using a solid-phase permethylation protocol. After the neutralization of sialic acids, they were analyzed by using MALDI-TOF MS and MALDI-QIT-TOF MS/MS.](molcell-38-1-65f2){#f2-molcell-38-1-65}

![Positive ion MALDI-TOF mass spectra of the *N*-glycans isolated from pig (A) wild-type and (B) GTKO fibroblasts. Major peaks detected by MALDI-TOF MS are numbered and total *N*-glycans are listed in the [Table 1](#t1-molcell-38-1-65){ref-type="table"}.](molcell-38-1-65f3){#f3-molcell-38-1-65}

![Relative quantitative comparison of (A) sialylated glycans, (B) fucosylated glycans, and (C) NeuGc-containing glycans. (\*\*\*P value \< 0.001, \*P value \< 0.05; P values were derived from the two-tailed Student *t*-test n = 3 for wild type pig fibroblasts/n = 3 for GalT-KO pig fibro-blasts. Error bars show SEM).](molcell-38-1-65f4){#f4-molcell-38-1-65}

![Positive ion MALDI-QIT-TOF MS/MS spectra of permethylated sialyl glycans observed at m/z values of (A) 2605.4, (B) 2966.6, (C) 3415.7, and (D) 3776.6.](molcell-38-1-65f5){#f5-molcell-38-1-65}

![Positive ion MALDI-QIT-TOF MS/MS spectra of the permethylated NeuGc-containing N-glycans observed at m/z (A) 2822.5 and (B) 2996.6.](molcell-38-1-65f6){#f6-molcell-38-1-65}

###### 

Identification of *N*-linked glycans derived from WT and GalT-KO pig fibroblasts

  Peak no.   \[M + Na\]^+^ *m/z*   Compositions   Proposed structure   \% total MALDI[^a^](#tfn1-molcell-38-1-65){ref-type="table-fn"}                                                                                                                             
  ---------- --------------------- -------------- -------------------- ----------------------------------------------------------------- ----------------------------- --- --- ----------------------------- ----------------------------------------------------- ---------------
  1          1579.8                1579.9         5                    2                                                                 0                             0   0   ![](molcell-38-1-65i1.jpg)    13.3 (± 0.60)                                         3.6 (± 0.35)
  2          1590.8                1590.9         3                    3                                                                 1                             0   0   ![](molcell-38-1-65i2.jpg)    2.1 (± 0.15)                                          0.5 (± 0.19)
  3          1620.8                1620.9         4                    3                                                                 0                             0   0   ![](molcell-38-1-65i3.jpg)    1.1 (± 0.28)                                          trace
  4          1661.8                1661.9         3                    4                                                                 0                             0   0   ![](molcell-38-1-65i4.jpg)    0.9 (± 0.21)                                          0.6 (± 0.23)
  5          1783.9                1784.0         6                    2                                                                 0                             0   0   ![](molcell-38-1-65i5.jpg)    3.4 (± 0.10)                                          0.5 (± 0.31)
  6          1794.9                1795.0         4                    3                                                                 1                             0   0   ![](molcell-38-1-65i6.jpg)    0.5 (± 0.08)                                          trace
  7          1824.9                1825.0         5                    3                                                                 0                             0   0   ![](molcell-38-1-65i7.jpg)    0.6 (± 0.09)                                          trace
  8          1835.9                1836.0         3                    4                                                                 1                             0   0   ![](molcell-38-1-65i8.jpg)    1.6 (± 0.15)                                          0.4 (± 0.18)
  9          1865.9                1866.0         4                    4                                                                 0                             0   0   ![](molcell-38-1-65i9.jpg)    0.4 (± 0.12)                                          trace
  10         1982.0                1982.1         4                    3                                                                 0                             1   0   ![](molcell-38-1-65i10.jpg)   1.5 (± 0.09)                                          1.0 (± 0.35)
  11         1988.0                1988.1         7                    2                                                                 0                             0   0   ![](molcell-38-1-65i11.jpg)   0.9 (± 0.13)                                          0.3 (± 0.08)
  12         1999.0                1999.1         5                    3                                                                 1                             0   0   ![](molcell-38-1-65i12.jpg)   0.6 (± 0.21)                                          0.1 (± 0.05)
  13         2040.0                2040.1         4                    4                                                                 1                             0   0   ![](molcell-38-1-65i13.jpg)   0.4 (± 0.05)                                          0.2 (± 0.02)
  14         2070.0                2070.1         5                    4                                                                 0                             0   0   ![](molcell-38-1-65i14.jpg)   0.4 (± 0.15)                                          trace
  15         2186.2                2186.2         4                    3 1                                                                                             0   1   ![](molcell-38-1-65i15.jpg)   1.9 (± 0.03)                                          1.2 (± 0.18)
  5          3 0                                  1                    0                                                                 ![](molcell-38-1-65i16.jpg)                                                                                               
  16         2192.1                2192.2         8                    2                                                                 0                             0   0   ![](molcell-38-1-65i17.jpg)   0.7 (± 0.19)                                          0.4 (± 0.04)
  17         2227.1                2227.2         4                    4                                                                 0                             1   0   ![](molcell-38-1-65i18.jpg)   3.7 (± 0.19)                                          2.0 (± 0.31)
  18         2244.2                2244.3         5                    4                                                                 1                             0   0   ![](molcell-38-1-65i19.jpg)   0.9 (± 0.05)                                          0.3 (± 0.02)
  19         2360.2                2360.3         5                    3                                                                 1                             1   0   ![](molcell-38-1-65i20.jpg)   trace                                                 0.4 (± 0.10)
  20         2390.2                2390.3         6                    3                                                                 0                             1   0   ![](molcell-38-1-65i21.jpg)   0.7 (± 0.17)                                          0.3 (± 0.24)
  21         2401.2                2401.3         4                    4                                                                 1                             1   0   ![](molcell-38-1-65i22.jpg)   1.4 (± 0.28)                                          1.4 (± 0.09)
  22         2431.2                2431.3         5                    4                                                                 0                             1   0   ![](molcell-38-1-65i23.jpg)   4.3 (± 0.11)                                          3.5 (± 0.22)
  23         2472.2                2472.4         4                    5                                                                 0                             1   0   ![](molcell-38-1-65i24.jpg)   1.1 (± 0.22)                                          0.7 (± 0.04)
  24         2547.3                2547.4         5                    3                                                                 0                             2   0   ![](molcell-38-1-65i25.jpg)   ND[^b^](#tfn2-molcell-38-1-65){ref-type="table-fn"}   1.3 (± 0.15)
  25         2605.3                2605.4         5                    4                                                                 1                             1   0   ![](molcell-38-1-65i26.jpg)   0.3 (± 0.08)                                          2.9 (± 0.13)
  26         2652.3                2652.4         7                    4                                                                 1                             0   0   ![](molcell-38-1-65i27.jpg)   0.6 (± 0.14)                                          ND
  27         2676.3                2676.4         5                    5                                                                 0                             1   0   ![](molcell-38-1-65i28.jpg)   0.4 (± 0.19)                                          0.2 (± 0.23)
  28         2764.4                2764.4         6                    6                                                                 0                             0   0   ![](molcell-38-1-65i29.jpg)   1.4 (± 0.26)                                          0.4 (± 0.38)
  29         2792.4                2792.4         5                    4                                                                 0                             2   0   ![](molcell-38-1-65i30.jpg)   17.2 (± 0.42)                                         15.3 (± 0.36)
  30         2822.4                2822.5         5                    4                                                                 0                             1   1   ![](molcell-38-1-65i31.jpg)   1.8 (± 0.36)                                          1.7 (± 0.07)
  31         2880.4                2880.5         6                    5                                                                 0                             1   0   ![](molcell-38-1-65i32.jpg)   0.3 (± 0.04)                                          0.2 (± 0.20)
  32         2966.5                2966.6         5                    4                                                                 1                             2   0   ![](molcell-38-1-65i33.jpg)   1.5 (± 0.10)                                          14.3 (± 0.46)
  33         2996.5                2996.6         5                    4                                                                 1                             1   1   ![](molcell-38-1-65i34.jpg)   0.2 (± 0.17)                                          2.2 (± 0.04)
  34         3037.5                3037.6         5                    5                                                                 0                             2   0   ![](molcell-38-1-65i35.jpg)   3.6 (± 0.25)                                          2.3 (± 0.12)
  35         3054.5                3054.5         6                    5                                                                 1                             1   0   ![](molcell-38-1-65i36.jpg)   0.4 (± 0.01)                                          0.9 (± 0.11)
  36         3153.6                3153.6         5                    4                                                                 0                             3   0   ![](molcell-38-1-65i37.jpg)   0.9 (± 0.06)                                          0.8 (± 0.34)
  37         3211.6                3211.7         5                    5                                                                 1                             2   0   ![](molcell-38-1-65i38.jpg)   0.3 (± 0.11)                                          0.4 (± 0.38)
  38         3241.6                3241.7         6                    5                                                                 0                             2   0   ![](molcell-38-1-65i39.jpg)   4.3 (± 0.36)                                          3.9 (± 0.03)
  39         3327.7                3327.7         5                    4                                                                 1                             3   0   ![](molcell-38-1-65i40.jpg)   0.1 (± 0.09)                                          0.4 (± 0.00)
  40         3415.7                3415.7         6                    5                                                                 1                             2   0   ![](molcell-38-1-65i41.jpg)   0.1 (± 0.21)                                          2.5 (± 0.49)
  41         3445.7                3445.8         6                    5                                                                 1                             1   1   ![](molcell-38-1-65i42.jpg)   0.2 (± 0.05)                                          0.2 (± 0.16)
  42         3503.7                3503.7         7                    6                                                                 1                             1   0   ![](molcell-38-1-65i43.jpg)   0.1 (± 0.09)                                          trace
  43         3602.8                3602.8         6                    5                                                                 0                             3   0   ![](molcell-38-1-65i44.jpg)   20.9 (± 0.26)                                         24.2 (± 1.25)
  44         3776.8                3776.7         6                    5                                                                 1                             3   0   ![](molcell-38-1-65i45.jpg)   ND                                                    2.9 (± 0.17)
  45         3806.9                3806.8         6                    5                                                                 1                             2   1   ![](molcell-38-1-65i46.jpg)   0.1 (± 0.08)                                          0.5 (± 0.07)
  46         3864.9                3864.8         7                    6                                                                 1                             2   0   ![](molcell-38-1-65i47.jpg)   trace                                                 0.7 (± 0.06)
  47         3964.0                3963.9         6                    5                                                                 0                             4   0   ![](molcell-38-1-65i48.jpg)   2.9 (± 0.11)                                          3.3 (± 0.14)

Quantitative sialylated and neutral N-glycan percentages measured by MALDI-TOF MS combined with solid-phase permethylation.

ND = not detected

Calculated masses

Experimental masses
